Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
Advances in vitiligo give patients hope
Vitiligo can be psychologically devastating for patients. Expert Seemal R. Desai, M.D., FAAD, shares how recent advances in vitiligo treatment offer hope to patients impacted by the disease.
“I think vitiligo is one of these conditions that’s been ignored for so long and right now my passion and excitement is that we are able to talk to our patients and give them hope,” says Dr. Desai.
Don’t miss the rest of our series on vitiligo, in which Dr. Desai’s shares vitiligo management pearls from his presentation at the AAD Virtual Meeting Experience (VMX):
- Talk to your vitiligo patients about their treatment goals
- How to classify disease activity in vitiligo patients
- Best practices for unstable vitiligo
- The role of antioxidants in vitiligo treatment
- What’s new in vitiligo treatment?
- Vitiligo subtypes indicate unstable, active disease
For more about AAD VMX, click here.
Reference
Desai S. What's New in Vitiligo. Therapeutic Hotline. AAD VMX 2020; June 12, 2020.
Related Videos
Related Content
